$Orphazyme A/S(ORPH)$Anybody know when will the FDA release the results regarding the approval of arimocromol for the treatment of Niemann pick disease type C? I’m betting high hopes foran approval of this drug by FDA, because if you think from a logical viewpoint, FDA has approved lots of drugs in the past, and given this is the second time Orphazyme has submitted for approval since the failure from May, they would have surely worked their way around the failure which givesus high hopes that this stock will skyrocket tonight!! Stick with me guys, it’s surely gonna be a positive result 🚀🚀🚀, let’s all make money to get a Lambo hahaha 😝